Effect of Intramuscular Interferon beta-1a on Gray Matter Atrophy in Relapsing-Remitting Multiple Sclerosis

被引：0
|
作者：
Nakamura, Kunio
Rudick, Richard
Lee, Jar-Chi
Foulds, Pamela
Fisher, Elizabeth
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A407 / A407
页数：1
相关论文
共 50 条
  • [31] Effect of daclizumab HYP versus intramuscular interferon beta-1a on no evidence of disease activity in patients with relapsing-remitting multiple sclerosis: analysis of the DECIDE study
    Kappos, L.
    Havrdova, E.
    Giovannoni, G.
    Khatri, B. O.
    Gauthier, S. A.
    Greenberg, S.
    Wang, P.
    Elkins, J.
    Barbato, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 22 - 22
  • [32] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S746 - S746
  • [33] PAYER AND SOCIETAL BENEFIT OF PEGINTERFERON BETA-1A VERSUS SUBCUTANEOUS INTERFERON BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gitlin, M.
    Snyder, S.
    Jhaveri, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S744 - S744
  • [34] Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers
    Bussas, Matthias
    Grahl, Sophia
    Pongratz, Viola
    Berthele, Achim
    Gasperi, Christiane
    Andlauer, Till
    Gaser, Christian
    Kirschke, Jan S.
    Wiestler, Benedikt
    Zimmer, Claus
    Hemmer, Bernhard
    Muehlau, Mark
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (06) : 900 - 909
  • [35] Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis
    Bendfeldt, K.
    Radue, E. W.
    Borgwardt, S. J.
    Kappos, L.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 (1-2) : 268 - 269
  • [36] Brain atrophy in relapsing-remitting multiple sclerosis:: Fractional volumetric analysis of gray matter and white matter
    Ge, YL
    Grossman, RI
    Udupa, JK
    Babb, JS
    Nyúl, LG
    Kolson, DL
    [J]. RADIOLOGY, 2001, 220 (03) : 606 - 610
  • [37] Effect of different dosages of interferon beta-1a in relapsing-remitting MS patients
    Cocco, E
    Marchi, R
    Floris, G
    Mascia, MG
    Lai, M
    Deriu, M
    Sirco, A
    Mamusa, E
    Frau, J
    Marrosu, MG
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S77 - S77
  • [38] Binding and Neutralising Antibodies in Relapsing-remitting Multiple Sclerosis Patients Treated with a Biosimilar Interferon Beta-1a (CinnoVex®)
    Sh, Nafissi
    Shahkarami, M. Amir
    Lam, R.
    Oger, J.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (02): : 273 - 273
  • [39] Relapsing-remitting Multiple Sclerosis Treated with Interferon Beta-1a 44 μg from the Onset - a Case Report
    Kurkova, B.
    Hradilek, P.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 : 32 - 34
  • [40] Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis
    Liu, Ying
    Vollmer, Timothy
    Havrdova, Eva
    Riester, Katherine
    Lee, Andrew
    Phillips, Glenn
    Wang, Ping
    Sabatella, Guido
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 11 : 18 - 24
12345